Raphael Pharmaceutical (RAPH) Other financing activities (2022 - 2024)

Raphael Pharmaceutical (RAPH) reported Other financing activities of $50000.0 for Q1 2024, up 400.0% sequentially from $10000.0 in Q1 2022.

Raphael Pharmaceutical (RAPH) Other financing activities (2022 - 2024) Analysis & Trends

Raphael Pharmaceutical (RAPH) has 2 years of Other financing activities data on file, last reported at $50000.0 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Raphael Pharmaceutical	27.37 Mn	27.33 Mn	-

Download Data